{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:38:01Z","timestamp":1789583881968,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11655-025-3932-8","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:38:18Z","timestamp":1767595098000},"page":"771-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Andrographolide Sulfonate Injection for Adjunctive Treatment of Non-severe Community-Acquired Pneumonia in Adults: A Multicenter, Double-Blind, Randomized Controlled Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Lian-han","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-hui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-zhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-shuai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-gang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"3932_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204\u20131222.","journal-title":"Lancet"},{"key":"3932_CR2","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/crj.12674","volume":"12","author":"B Cao","year":"2018","unstructured":"Cao B, Huang Y, She DY, Cheng QJ, Fan H, Tian XL, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J 2018;12:1320\u20131360.","journal-title":"Clin Respir J"},{"key":"3932_CR3","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1016\/j.vaccine.2020.11.004","volume":"38","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li H, Pei Z, Wang S, Feng J, Xu L, et al. Incidence of community-acquired pneumonia in urban China: a national population-based study. Vaccine 2020;38:8362\u20138370.","journal-title":"Vaccine"},{"key":"3932_CR4","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","volume":"65","author":"JA Ramirez","year":"2017","unstructured":"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis 2017;65:1806\u20131812.","journal-title":"Clin Infect Dis"},{"key":"3932_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s10096-020-03870-3","volume":"39","author":"M Carugati","year":"2020","unstructured":"Carugati M, Aliberti S, Sotgiu G, Blasi F, Gori A, Menendez R, et al. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. Eur J Clin Microbiol Infect Dis 2020;39:1513\u20131525.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3932_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415\u2013427.","journal-title":"N Engl J Med"},{"key":"3932_CR7","doi-asserted-by":"publisher","first-page":"1802406","DOI":"10.1183\/13993003.02406-2018","volume":"54","author":"F Zhou","year":"2019","unstructured":"Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X, et al. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. Eur Respir J 2019;54:1802406.","journal-title":"Eur Respir J"},{"key":"3932_CR8","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200:e45\u2013e67.","journal-title":"Am J Respir Crit Care Med"},{"key":"3932_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","volume":"158","author":"R Cavallazzi","year":"2020","unstructured":"Cavallazzi R, Furmanek S, Arnold FW, Beavin LA, Wunderink RG, Niederman MS, et al. The burden of community-acquired pneumonia requiring admission to ICU in the United States. Chest 2020;158:1008\u20131016.","journal-title":"Chest"},{"key":"3932_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2024.14796","volume":"332","author":"VM Vaughn","year":"2024","unstructured":"Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-acquired pneumonia: a review. JAMA 2024;332:1282\u20131295.","journal-title":"JAMA"},{"key":"3932_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/thorax-2024-222296","volume":"80","author":"I Martin-Loeches","year":"2025","unstructured":"Martin-Loeches I, Reyes LF, Rodriguez A. Severe community-acquired pneumonia (sCAP): advances in management and future directions. Thorax 2025;80:565\u2013575.","journal-title":"Thorax"},{"key":"3932_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00134-025-07903-3","volume":"51","author":"P Povoa","year":"2025","unstructured":"Povoa P, Coelho L, Carratala J, Cawcutt K, Cosgrove SE, Ferrer R, et al. How to approach a patient hospitalized for pneumonia who is not responding to treatment? Intensive Care Med 2025;51:893\u2013903.","journal-title":"Intensive Care Med"},{"key":"3932_CR13","doi-asserted-by":"publisher","first-page":"ofaa065","DOI":"10.1093\/ofid\/ofaa065","volume":"7","author":"G Tillotson","year":"2020","unstructured":"Tillotson G, Lodise T, Classi P, Mildvan D, McKinnell JA. Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: a real-world US insurance claims database study. Open Forum Infect Dis 2020;7:ofaa065.","journal-title":"Open Forum Infect Dis"},{"key":"3932_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 2025;25:1033\u20131043.","journal-title":"Lancet Infect Dis"},{"key":"3932_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/ph18020183","volume":"18","author":"Z Li","year":"2025","unstructured":"Li Z, Yao L, Liu Z, Wang L, Ruan H, Shen Y, et al. Andrographolide sulfonates and Xiyanping: a review of chemical composition, pharmacological activities, clinical applications, and adverse reactions. Pharmaceuticals (Basel) 2025;18:183.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3932_CR16","doi-asserted-by":"publisher","first-page":"109065","DOI":"10.1016\/j.biopha.2019.109065","volume":"117","author":"G Zhang","year":"2019","unstructured":"Zhang G, Jiang C, Xie N, Xu Y, Liu L, Liu N. Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia. Biomed Pharmacother 2019;117:109065.","journal-title":"Biomed Pharmacother"},{"key":"3932_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.apsb.2016.02.002","volume":"6","author":"S Peng","year":"2016","unstructured":"Peng S, Hang N, Liu W, Guo W, Jiang C, Yang X, et al. Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-kappaB pathways. Acta Pharm Sin B 2016;6:205\u2013211.","journal-title":"Acta Pharm Sin B"},{"key":"3932_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3389\/fphys.2018.00939","volume":"9","author":"F Gao","year":"2018","unstructured":"Gao F, Liu X, Shen Z, Jia X, He H, Gao J, et al. Andrographolide sulfonate attenuates acute lung injury by reducing expression of myeloperoxidase and neutrophil-derived proteases in mice. Front Physiol 2018;9:939.","journal-title":"Front Physiol"},{"key":"3932_CR19","first-page":"5282","volume":"44","author":"ZF Wang","year":"2019","unstructured":"Wang ZF, Zhang HC, Xie YM, Miao Q, Sun ZT, Wang RB, et al. Expert consensus statement on Xiyanping Injection for respiratory system infectious diseases in clinical practice (adults). China J Chin Mater Med (Chin) 2019;44:5282\u20135286.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"3932_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11655-024-3909-z","volume":"31","author":"QQ Xu","year":"2025","unstructured":"Xu QQ, Yu DD, Fan XD, Cui HR, Dai QQ, Zhong XY, et al. Chinese medicine for treatment of COVID-19: a review of potential pharmacological components and mechanisms. Chin J Integr Med 2025;31:83\u201395.","journal-title":"Chin J Integr Med"},{"key":"3932_CR21","doi-asserted-by":"publisher","first-page":"153009","DOI":"10.1016\/j.phymed.2019.153009","volume":"63","author":"X Huang","year":"2019","unstructured":"Huang X, Duan X, Zhu Y, Wang K, Wu J, Tian X. Comparative efficacy of Chinese herbal injections for the treatment of community-acquired pneumonia: a Bayesian network meta-analysis of randomized controlled trials. Phytomedicine 2019;63:153009.","journal-title":"Phytomedicine"},{"key":"3932_CR22","first-page":"468","volume":"49","author":"Y Wang","year":"2018","unstructured":"Wang Y, Lv L, Fan H, Xu H. Meta-analysis on effectiveness and safety of Xiyanping Injection combined with antibiotics in treatment of CAP in adults. Chin Tradit Herb Drugs (Chin) 2018;49:468\u2013476.","journal-title":"Chin Tradit Herb Drugs (Chin)"},{"key":"3932_CR23","doi-asserted-by":"publisher","first-page":"106919","DOI":"10.1016\/j.phrs.2023.106919","volume":"196","author":"M Wang","year":"2023","unstructured":"Wang M, Liu H, Chen Y, Yu J, Lin J, Sun Z, et al. Guideline on treating community-acquired pneumonia with Chinese patent medicines. Pharmacol Res 2023;196:106919.","journal-title":"Pharmacol Res"},{"key":"3932_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/1995-7645.280222","volume":"13","author":"B Ding","year":"2020","unstructured":"Ding B, Fang B, Li J, Liu Q, Lv C, Yu X, et al. Expert consensus guidelines on clinical use of Xiyanping Injection for acute infectious diseases. Asian Pacific J Tropic Med 2020;13:152\u2013161.","journal-title":"Asian Pacific J Tropic Med"},{"key":"3932_CR25","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147\u2013e239.","journal-title":"J Am Coll Cardiol"},{"key":"3932_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0197-2456(00)00104-5","volume":"21","author":"FY Hsieh","year":"2000","unstructured":"Hsieh FY, Lavori PW. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 2000;21:552\u2013560.","journal-title":"Control Clin Trials"},{"key":"3932_CR27","doi-asserted-by":"publisher","first-page":"2400054","DOI":"10.1183\/13993003.00054-2024","volume":"64","author":"S Bastrup Israelsen","year":"2024","unstructured":"Bastrup Israelsen S, Fally M, Brok Nielsen P, Kolte L, Karmark Iversen K, Ravn P, et al. Reassessing Halm\u2019s clinical stability criteria in community-acquired pneumonia management. Eur Respir J 2024;64:2400054.","journal-title":"Eur Respir J"},{"key":"3932_CR28","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.3390\/jcm14155273","volume":"14","author":"Y Sharma","year":"2025","unstructured":"Sharma Y, Mangoni AA, Shahi R, Horwood C, Thompson C. Clinical instability at discharge and post-discharge outcomes in patients with community-acquired pneumonia: an observational study. J Clin Med 2025;14:5273.","journal-title":"J Clin Med"},{"key":"3932_CR29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","volume":"397","author":"A Dinh","year":"2021","unstructured":"Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, et al. Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397:1195\u20131203.","journal-title":"Lancet"},{"key":"3932_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12879-020-05362-3","volume":"20","author":"X Han","year":"2020","unstructured":"Han X, Liu X, Chen L, Wang Y, Li H, Zhou F, et al. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis 2020;20:668.","journal-title":"BMC Infect Dis"},{"key":"3932_CR31","doi-asserted-by":"publisher","first-page":"e2129566","DOI":"10.1001\/jamanetworkopen.2021.29566","volume":"4","author":"A Dinh","year":"2021","unstructured":"Dinh A, Duran C, Ropers J, Bouchand F, Davido B, Deconinck L, et al. Factors associated with treatment failure in moderately severe community-acquired pneumonia: a secondary analysis of a randomized clinical trial. JAMA Netw Open 2021;4:e2129566.","journal-title":"JAMA Netw Open"},{"key":"3932_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ccm.2018.07.008","volume":"39","author":"A Ceccato","year":"2018","unstructured":"Ceccato A, Ferrer M, Barbeta E, Torres A. Adjunctive therapies for community-acquired pneumonia. Clin Chest Med 2018;39:753\u2013764.","journal-title":"Clin Chest Med"},{"key":"3932_CR33","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1055\/s-0036-1593538","volume":"37","author":"O Sibila","year":"2016","unstructured":"Sibila O, Rodrigo-Troyano A, Torres A. Nonantibiotic adjunctive therapies for community-acquired pneumonia (corticosteroids and beyond): where are we with them? Semin Respir Crit Care Med 2016;37:913\u2013922.","journal-title":"Semin Respir Crit Care Med"},{"key":"3932_CR34","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","volume":"59","author":"Y Dai","year":"2019","unstructured":"Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr 2019;59:S17\u2013S29.","journal-title":"Crit Rev Food Sci Nutr"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3932-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-3932-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3932-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:56:10Z","timestamp":1786787770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-3932-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3932"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-3932-8","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"10 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jiangxi Qingfeng Pharmaceutical Co., Ltd. provided partial funding for the project, but did not participate in the study design, data collection, data analysis, data interpretation, or writing of the report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}